Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Vemulapalli

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Infection and Immunity|August 14, 2001
Induction of specific cytotoxic lymphocytes in mice vaccinated with Brucella abortus RB51Y He, R Vemulapalli, A Zeytun, et al.
Veterinary Pathology|April 9, 2010
Systemic sarcocystosis in a striped skunk (Mephitis mephitis)G N Burcham, J A Ramos-Vara, R Vemulapalli
British Journal of Pharmacology|December 12, 2001
Activation of central melanocortin receptors by MT-II increases cavernosal pressure in rabbits by the neuronal release of NOR Vemulapalli, S Kurowski, B Salisbury, et al.
Infection and Immunity|May 19, 2000
Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responsesR Vemulapalli, Y He, S M Boyle, et al.
The American Journal of Physiology|April 8, 1998
Downregulation of a human colonic sialyltransferase by a secondary bile acid and a phorbol esterM Li, R Vemulapalli, A Ullah, et al.
Infection and Immunity|May 19, 2000
Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51R Vemulapalli, Y He, S Cravero, et al.
Infection and Immunity|January 23, 1999
Vaccination with live Escherichia coli expressing Brucella abortus Cu/Zn superoxide dismutase protects mice against virulent B. abortusA A Oñate, R Vemulapalli, E Andrews, et al.
Gene Therapy|February 19, 2010
Evaluation of cross-reactive cell-mediated immune responses among human, bovine and porcine adenovirusesA Sharma, M Tandon, Y S Ahi, et al.
Infection and Immunity|June 17, 2000
Complementation of Brucella abortus RB51 with a functional wboA gene results in O-antigen synthesis and enhanced vaccine efficacy but no change in rough phenotype and attenuationR Vemulapalli, Y He, L S Buccolo, et al.
Clinical and Diagnostic Laboratory Immunology|September 3, 1999
Identification of an IS711 element interrupting the wboA gene of Brucella abortus vaccine strain RB51 and a PCR assay to distinguish strain RB51 from other Brucella species and strainsR Vemulapalli, J R McQuiston, G G Schurig, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Infection and Immunity|August 14, 2001
Induction of specific cytotoxic lymphocytes in mice vaccinated with Brucella abortus RB51Y He, R Vemulapalli, A Zeytun, et al.
Veterinary Pathology|April 9, 2010
Systemic sarcocystosis in a striped skunk (Mephitis mephitis)G N Burcham, J A Ramos-Vara, R Vemulapalli
British Journal of Pharmacology|December 12, 2001
Activation of central melanocortin receptors by MT-II increases cavernosal pressure in rabbits by the neuronal release of NOR Vemulapalli, S Kurowski, B Salisbury, et al.
Infection and Immunity|May 19, 2000
Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responsesR Vemulapalli, Y He, S M Boyle, et al.
The American Journal of Physiology|April 8, 1998
Downregulation of a human colonic sialyltransferase by a secondary bile acid and a phorbol esterM Li, R Vemulapalli, A Ullah, et al.
Infection and Immunity|May 19, 2000
Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51R Vemulapalli, Y He, S Cravero, et al.
Infection and Immunity|January 23, 1999
Vaccination with live Escherichia coli expressing Brucella abortus Cu/Zn superoxide dismutase protects mice against virulent B. abortusA A Oñate, R Vemulapalli, E Andrews, et al.
Gene Therapy|February 19, 2010
Evaluation of cross-reactive cell-mediated immune responses among human, bovine and porcine adenovirusesA Sharma, M Tandon, Y S Ahi, et al.
Infection and Immunity|June 17, 2000
Complementation of Brucella abortus RB51 with a functional wboA gene results in O-antigen synthesis and enhanced vaccine efficacy but no change in rough phenotype and attenuationR Vemulapalli, Y He, L S Buccolo, et al.
Clinical and Diagnostic Laboratory Immunology|September 3, 1999
Identification of an IS711 element interrupting the wboA gene of Brucella abortus vaccine strain RB51 and a PCR assay to distinguish strain RB51 from other Brucella species and strainsR Vemulapalli, J R McQuiston, G G Schurig, et al.
Pageof 3